Bone Morphogenetic Protein-4 Promotes Phenotypic Modulation via SMAD-4/MCT-4 Axis in Vascular Smooth Muscle Cells

J Vasc Res. 2024;61(3):99-108. doi: 10.1159/000532029. Epub 2023 Dec 27.

Abstract

Introduction: This study aimed to determine whether bone morphogenetic protein-4 (BMP-4), which increases in response to intimal hyperplasia, promotes phenotype transition in vascular smooth muscle cells (VSMCs).

Methods: Balloon injury was used to induce intimal hyperplasia in rats. Hematoxylin-eosin staining was used to detect the alteration of vascular structure. Serum levels of BMP-4 and lactate were detected by ELISA. Human aortic smooth muscle cells (HA-SMCs) were cultured. Protein and mRNA expression levels were detected through Western blot and real-time PCR. Cell migration was measured by transwell assay.

Results: Our data showed that serum concentration of BMP-4 was upregulated after balloon injury. Treatment with BMP-4 inhibitor DMH1 (4-(6-(4-isopropoxyphenyl)pyrazolo(1,5-a)pyrimidin-3-yl)quinoline) suppressed the abnormal expression of BMP-4 and inhibited the intimal hyperplasia induced by balloon injury. Compared to BMP-4-negative medium, BMP-4-positive medium was associated with higher synthetic VSMC marker expression levels and lower in contractile gene markers in cultured HA-SMCs. Transfection of monocarboxylic acid transporters-4 (MCT-4) siRNA inhibited the excretion of lactate induced by BMP-4.

Conclusion: Our analyses provided evidence that BMP-4 and its regulator Smad-4 are key regulators in MCT-4-mediated lactate excretion. This indicates that BMP-4 stimulates the phenotypic transition of VSMCs via SMAD-4/MCT-4 signaling pathway.

Keywords: BMP-4; MCT-4; Neointimal hyperplasia; Phenotype transition; Vascular smooth muscle cells.

MeSH terms

  • Angioplasty, Balloon / adverse effects
  • Animals
  • Bone Morphogenetic Protein 4* / genetics
  • Bone Morphogenetic Protein 4* / metabolism
  • Cell Movement* / drug effects
  • Cell Plasticity / drug effects
  • Cells, Cultured
  • Disease Models, Animal*
  • Humans
  • Hyperplasia*
  • Lactic Acid / blood
  • Lactic Acid / metabolism
  • Male
  • Monocarboxylic Acid Transporters* / genetics
  • Monocarboxylic Acid Transporters* / metabolism
  • Muscle, Smooth, Vascular* / drug effects
  • Muscle, Smooth, Vascular* / metabolism
  • Muscle, Smooth, Vascular* / pathology
  • Myocytes, Smooth Muscle* / drug effects
  • Myocytes, Smooth Muscle* / metabolism
  • Myocytes, Smooth Muscle* / pathology
  • Neointima*
  • Phenotype*
  • Rats, Sprague-Dawley*
  • Signal Transduction*
  • Smad4 Protein* / genetics
  • Smad4 Protein* / metabolism
  • Vascular System Injuries / genetics
  • Vascular System Injuries / metabolism
  • Vascular System Injuries / pathology

Substances

  • Bone Morphogenetic Protein 4
  • Smad4 Protein
  • Bmp4 protein, rat
  • Monocarboxylic Acid Transporters
  • BMP4 protein, human
  • SMAD4 protein, human
  • Lactic Acid